Clinical trials

BERGAMO TRIAL: A phase II study evaluating the efficacy and safety of Bemcentinib in patients with MDS or AML failing standard of care therapy
Status: recruiting in Germany

DACOTA TRIAL (NCT02214407): Randomized Phase III study of Decitabine (DAC) with or without Hydroxyurea (HY) versus HY in patients with advanced proliferative Chronic Myelomonocytic Leukemia (CMML)
Status: recruiting in France and Germany
[Download German study flyer]

EUROPE TRIAL (NCT02335268): Prospective validation of a predictive model of response to romiplostim in patients with IPSS low or intermediate-1 risk myelodysplastic syndrome (MDS) and thrombocytopenia
Status: recruiting in France and Germany
[Download German study flyer]

SINTRA-REV TRIAL (NCT01243476): Multicenter, randomized, double-blind, phase III study of Revlimid® (Lenalidomide) versus Placebo in patients with low risk myelodysplastic syndrome (low and intermediate-1 IPSS) with alteration in 5q and anemia without the need of transfusion
Status: recruitment completed
[Download German study flyer]

SAMBA TRIAL (NCT02992860): Single agent JNJ-56022473 in MDS and AML patients failing hypomethylating agent based therapy
Status: prematurely terminated